Search

Home > OncLive® On Air > 5: FDA Approval Insights: Cemiplimab in Advanced PD-L1–High NSCLC and Advanced Basal Cell Carcinoma
Podcast: OncLive® On Air
Episode:

5: FDA Approval Insights: Cemiplimab in Advanced PD-L1–High NSCLC and Advanced Basal Cell Carcinoma
Category: Science & Medicine
Duration: 00:13:59
Publish Date: 2021-05-06 20:20:14
Description: Dr. Sezar and Dr. Stratigos discuss the FDA approvals of cemiplimab-rwlc in advanced non–small cell lung cancer and advanced basal cell carcinoma.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..